It May Be Time to Sell Shares of Segro (LON:SGRO) as JP Morgan Cazenove Has Downgraded The Company

Share

Segro (LON:SGRO) Receives a Downgrade

In an analyst research report sent to investors and clients on Wednesday morning, JP Morgan Cazenove lowered their rating for shares of Segro (LON:SGRO) to a “Neutral” and they now have a GBX 485.00 TP on the stock. JP Morgan Cazenove’s TP gives a possible upside of 13.62% from the last stock close price of Segro (LON:SGRO).

From a total of 18 analysts covering Segro (LON:SGRO) stock, 6 rate it a ”Buy”, 0 a “Sell”, and 13 a ”Hold”. This means that 32% of the ratings are positive. The highest target price is GBX 550 while the lowest target price is GBX 400. The mean of all analyst targets is GBX 469.72 with a 8.05% above today’s (GBX 426.88) stock price. Segro was the topic of 39 analyst reports since July 22, 2015 according to the firm StockzIntelligence Inc. Jefferies maintained shares on December 14 with “Hold” rating. Barclays Capital maintained shares with “Equal Weight” rating and GBX 450 target share price in a report from an October 30. Kempen & Co maintained SGRO stock in a recent report from November 23 with “Neutral” rating. Deutsche Bank maintained the rating on October 22. Deutsche Bank has a “Hold” rating and a GBX 400 price target on shares. Finally, Peel Hunt maintained the stock with “Hold” rating in a report issued on a November 23.

The stock decreased 0.54% or GBX 2.32 on December 15, striking GBX 426.88. Approximately shares of stock traded hands. SEGRO plc (LON:SGRO) has risen 0.42% since May 19, 2015 and is uptrending. It has outperformed by 4.10% the S&P500.

 It May Be Time to Sell Shares of Segro (LON:SGRO) as JP Morgan Cazenove Has Downgraded The Company

SEGRO plc is a real estate investment trust. The company has a market cap of 3.13 billion GBP. The Firm owns, develops and manages warehouse and industrial property assets in the United Kingdom and Continental Europe. It has 3.99 P/E ratio. The Company’s portfolio of warehouse and light industrial buildings are located in four European countries: the United Kingdom, France, Germany and Poland.

COMMENTS: